Fig. 3From: Adverse reproductive health outcomes in a cohort of young women with breast cancer exposed to systemic treatmentsPatients’ levels of OR markers at the last follow-up, ordered according to menstruation status (Y/N), and their comparison with the corresponding expected levels for age (AMH, AFC) or the cut-off value of 25 mIU/mL (FSH)Back to article page